纳米载体
DNA折纸
药物输送
纳米技术
生物相容性
适体
体内分布
DNA纳米技术
纳米结构
靶向给药
材料科学
DNA
自组装
纳米材料
纳米颗粒
化学
生物
生物技术
体内
分子生物学
生物化学
冶金
作者
Jorieke Weiden,Maartje M. C. Bastings
标识
DOI:10.1016/j.cocis.2020.101411
摘要
DNA nanostructures are emerging as a versatile platform for controlled drug delivery as a result of recent progress in production yield and strategies to obtain prolonged stability in biological environments. The construction of nanostructures from this unique biomaterial provides unparalleled control over structural and functional parameters. Recent applications of DNA origami-based nanocarriers for therapeutic drug delivery in preclinical phases highlight them as promising alternatives to conventional nanomaterials, as they benefit from the inherent favorable properties of DNA including biocompatibility and precise spatial addressability. By incorporating targeting aptamers and responsive properties into the nanocarrier design, more selective DNA origami-based nanocarriers are successfully prepared. On the other hand, current systems remain poorly understood in terms of biodistribution, final fate, and controlled drug release. As such, advances are needed to translate this material platform in its full potential for therapeutic applications. • Advances in prolonged stability of DNA origami allow biomedical applications. • Drug delivery can benefit from the high programmability and biocompatibility of DNA. • Targeting aptamers and responsive drug release enhance drug selectivity. • DNA origami biodistribution and controlled drug release need better understanding. • Surprisingly, DNA origami nanostructure production costs will not hinder translation.
科研通智能强力驱动
Strongly Powered by AbleSci AI